170 related articles for article (PubMed ID: 10361249)
21. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q.
Lu JH; Thiel S; Wiedemann H; Timpl R; Reid KB
J Immunol; 1990 Mar; 144(6):2287-94. PubMed ID: 2313094
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.
Hart ML; Ceonzo KA; Shaffer LA; Takahashi K; Rother RP; Reenstra WR; Buras JA; Stahl GL
J Immunol; 2005 May; 174(10):6373-80. PubMed ID: 15879138
[TBL] [Abstract][Full Text] [Related]
23. Regulation of C3 deposition on gp120 coated CD4 positive cells by decay accelerating factor and factor H.
Sadlon TA; Parker SJ; Gordon DL
Immunol Cell Biol; 1994 Dec; 72(6):461-70. PubMed ID: 7535292
[TBL] [Abstract][Full Text] [Related]
24. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
Kuraya M; Yefenof E; Klein G; Klein E
Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
[TBL] [Abstract][Full Text] [Related]
25. Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3.
Matsumoto M; Yamashita F; Iida K; Tomita M; Seya T
J Exp Med; 1995 Jan; 181(1):115-25. PubMed ID: 7806998
[TBL] [Abstract][Full Text] [Related]
26. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.
Kang YS; Do Y; Lee HK; Park SH; Cheong C; Lynch RM; Loeffler JM; Steinman RM; Park CG
Cell; 2006 Apr; 125(1):47-58. PubMed ID: 16615889
[TBL] [Abstract][Full Text] [Related]
27. Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions.
Harboe M; Garred P; Borgen MS; Stahl GL; Roos A; Mollnes TE
Clin Exp Immunol; 2006 Jun; 144(3):512-20. PubMed ID: 16734621
[TBL] [Abstract][Full Text] [Related]
28. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
29. MASP1 (MBL-associated serine protease 1).
Matsushita M; Endo Y; Fujita T
Immunobiology; 1998 Aug; 199(2):340-7. PubMed ID: 9777417
[TBL] [Abstract][Full Text] [Related]
30. Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin.
Matsushita M; Matsushita A; Endo Y; Nakata M; Kojima N; Mizuochi T; Fujita T
Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10127-31. PubMed ID: 15218103
[TBL] [Abstract][Full Text] [Related]
31. Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.
Zhang MX; Kozel TR
Infect Immun; 1998 Oct; 66(10):4845-50. PubMed ID: 9746588
[TBL] [Abstract][Full Text] [Related]
32. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway.
Banda NK; Takahashi K; Wood AK; Holers VM; Arend WP
J Immunol; 2007 Sep; 179(6):4101-9. PubMed ID: 17785849
[TBL] [Abstract][Full Text] [Related]
33. A second serine protease associated with mannan-binding lectin that activates complement.
Thiel S; Vorup-Jensen T; Stover CM; Schwaeble W; Laursen SB; Poulsen K; Willis AC; Eggleton P; Hansen S; Holmskov U; Reid KB; Jensenius JC
Nature; 1997 Apr; 386(6624):506-10. PubMed ID: 9087411
[TBL] [Abstract][Full Text] [Related]
34. Homologous C3 deposition and homotypic cell adhesion in a human myeloid cell line, P39.
Matsumoto M; Seya T
Eur J Immunol; 1993 Sep; 23(9):2270-8. PubMed ID: 8103747
[TBL] [Abstract][Full Text] [Related]
35. Human L-ficolin, a recognition molecule of the lectin activation pathway of complement, activates complement by binding to pneumolysin, the major toxin of Streptococcus pneumoniae.
Ali YM; Kenawy HI; Muhammad A; Sim RB; Andrew PW; Schwaeble WJ
PLoS One; 2013; 8(12):e82583. PubMed ID: 24349316
[TBL] [Abstract][Full Text] [Related]
36. Activation of complement on the surface of cells infected by human immunodeficiency virus.
Spear GT; Landay AL; Sullivan BL; Dittel B; Lint TF
J Immunol; 1990 Feb; 144(4):1490-6. PubMed ID: 1968081
[TBL] [Abstract][Full Text] [Related]
37. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella.
Schweinle JE; Ezekowitz RA; Tenner AJ; Kuhlman M; Joiner KA
J Clin Invest; 1989 Dec; 84(6):1821-9. PubMed ID: 2592561
[TBL] [Abstract][Full Text] [Related]
38. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
Santi P; Joiner KA; Hammer CH; Frank MM; Tosi R
J Immunol; 1987 May; 138(10):3385-91. PubMed ID: 2952716
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells.
Marschang P; Gürtler L; Tötsch M; Thielens NM; Arlaud GJ; Hittmair A; Katinger H; Dierich MP
AIDS; 1993 Jul; 7(7):903-10. PubMed ID: 7689323
[TBL] [Abstract][Full Text] [Related]
40. Binding to complement factors and activation of the alternative pathway by Acanthamoeba.
Pumidonming W; Walochnik J; Dauber E; Petry F
Immunobiology; 2011; 216(1-2):225-33. PubMed ID: 20627448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
